Kurt R. Gehlsen, Ph.D.

Vice President and Chief Scientific Officer

Gehlsen provides scientific leadership in the review and oversight of RCT's biomedical investment activities. He works closely with the company's technology identification, development and business functions. Gehlsen has 20 years experience working in private and public companies, pharmaceutical product development, basic research, clinical development, regulatory affairs, strategic planning, business development, investor relations and executive management.

Professional Experience

Research Corporation Technologies
Vice President & Chief Scientific Officer, 2005-present

Maxim Pharmaceuticals Inc.
Senior Vice President, Development & Chief Scientific Officer, 1996-2004

Sidney Kimmel Cancer Center
Associate Professor, 1995-2001

Trauma Products Inc.
Founder & Chief Executive Officer, 1993-1995

California Institute for Biological Research
Associate Staff Scientist, 1993-1995

La Jolla Institute for Experimental Medicine
Vice President & Chief Operating Officer, 1990-1993

Pharmacia Inc.
Director of Research, Experimental Medicine Division, 1989-1993

La Jolla Cancer Research Foundation
Research Associate, 1988-1989
Postdoctoral Fellow, 1986-1988

Education

The University of Arizona College of Medicine
Ph.D., Anatomy, Physiology, Cancer Biology

The University of Arizona
B.S., Civil Engineering & General Biology, Minors in Chemistry, Physics & Mathematics

Contact

kgehlsen@rctech.com